A new master prepares the future regenmed


image: A WFIRM research associate prepares materials for cell processing.
see After

1 credit

WINSTON-SALEM, NC – October 11, 2022 – A new master’s program to prepare next and future generations of STEM professionals and business leaders for the field of regenerative medicine has been established at Wake Forest University School of Medicine in collaboration with regenerative medicine experts at the Wake Forest Institute for Regenerative Medicine (WFIRM).

The Translational Biotechnology MS program offers two tracks—research and business—with the goal of preparing graduates to lead the movement of new therapies from the lab to the clinic. The program works closely with the Wake Forest Institute for Regenerative Medicine.

Students can choose between two paths – research and business – in an effort to prepare to lead the effort to bring new therapies from the lab to the clinic. The program works closely with WFIRM faculty members who are internationally recognized leaders in regenerative medicine and tissue engineering.

“There is a strong regional need for highly qualified scientists with knowledge of business fundamentals and regulatory affairs, which specifically aligns with a report from the Council of Graduate Schools,” said Tracy Criswell, PhD, associate professor at WFIRM and director of the new program. “The field of regenerative medicine is rapidly expanding from its research and development to biomanufacturing to clinical translation, as new biological products and technologies are developed and production is scaled up to match their rate of development. ‘adoption.”

Both pathways of the program are flexibly designed to meet individual student needs.

The science/research oriented track is aimed at students with a four-year undergraduate degree in biomedical sciences who have a primary interest in research in academia or industry. Students will pursue a research project culminating in a written thesis and defense.

The business-focused track is aimed at students who are already professionals in their field (scientific or non-scientific) but who wish to gain knowledge about starting or running companies engaged in biotechnology. Online asynchronous courses will allow these students to obtain their MS while remaining employed. Students will complete a capstone project focused on their area of ​​interest.

Both paths require an externship (local or virtual) with a biotechnology partner organization. A Certificate in Translational Biotechnology is also offered, consisting of 15 credit hours of didactic coursework tailored to the needs of the student.

Criswell said the degree would be an advantage for anyone planning to work in environments such as:

  • Academic research and educational institutions, including undergraduate and professional schools
  • Pharmaceutical industry
  • Biotechnology companies or pharmaceutical start-ups
  • Government agencies, such as the Department of Defense, National Institutes of Health, or Food and Drug Administration

“This degree program is an integral part of the RegenMed Hub, a thriving regenerative medicine ecosystem in North Carolina that provides access to unparalleled resources to advance education, products, and manufacturing, with the ultimate goal of improve patient care,” said Anthony Atala, director. from WFIRM.

The application deadline is March 1. Full program and admissions information is available at the website.

About the Wake Forest Institute for Regenerative Medicine: The Wake Forest Institute for Regenerative Medicine is recognized as an international leader in translating scientific discoveries into clinical therapies, with many world firsts, including the development and implantation of the first modified organ in a patient. More than 400 people at the institute, the largest in the world, work on more than 40 different tissues and organs. A number of basic principles of tissue engineering and regenerative medicine were first developed at the institute. WFIRM researchers have successfully designed replacement tissues and organs in all four categories – flat structures, tubular tissues, hollow organs and solid organs – and 15 different applications of cell/tissue therapy technologies, such as skin, tissue Urethra, cartilage, bladders, muscles, kidneys, and vaginal organs have been used successfully in human patients. The institute, part of the Wake Forest School of Medicine, is located in the Innovation District in downtown Winston-Salem, North Carolina, and is driven by urgent patient needs. The institute is making a global difference in regenerative medicine through collaborations with more than 400 entities and institutions around the world, through its government, academic and industrial partnerships, its start-ups and through major initiatives in the technologies of advanced, such as tissue engineering, cell therapies. , diagnostics, drug discovery, biomanufacturing, nanotechnology, gene editing and 3D printing.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of press releases posted on EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

Source link


Comments are closed.